Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-081939

Chief Executive Officer sold 40,000 shares at an average $82.86 ($3,314,310)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BELANOFF JOSEPH K Chief Executive Officer 2025-06-02 Sale 10b5-1 −4,881 $78.42 $382,773 2,937,104 I
BELANOFF JOSEPH K Chief Executive Officer 2025-06-02 Sale 10b5-1 −3,050 $79.48 $242,421 2,934,054 I
BELANOFF JOSEPH K Chief Executive Officer 2025-06-02 Sale 10b5-1 −2,988 $80.30 $239,941 2,931,066 I
BELANOFF JOSEPH K Chief Executive Officer 2025-06-02 Sale 10b5-1 −1,820 $81.33 $148,012 2,929,246 I
BELANOFF JOSEPH K Chief Executive Officer 2025-06-02 Sale 10b5-1 −1,263 $82.26 $103,899 2,927,983 I
BELANOFF JOSEPH K Chief Executive Officer 2025-06-02 Sale 10b5-1 −4,631 $83.46 $386,523 2,923,352 I
BELANOFF JOSEPH K Chief Executive Officer 2025-06-02 Sale 10b5-1 −12,959 $84.57 $1,095,962 2,910,393 I
BELANOFF JOSEPH K Chief Executive Officer 2025-06-02 Sale 10b5-1 −8,408 $85.01 $714,778 2,901,985 I
Open-market sales · 40,000 sh · avg $82.86 · $3,314,310
Loading xslF345X05/ownership.xml…